Inflammatory myofibroblastic tumour of the larynx: report of a case
Related Experiment Video
Updated: Sep 24, 2025
07:30
Learning Modern Laryngeal Surgery in a Dissection Laboratory
Published on: March 18, 2020
8.2K
Andrea Colizza1, Piero Giuseppe Meliante1, Samantha Donsante2
1Department of Sense Organs, Sapienza University of Rome, Italy.
Ear, Nose, & Throat Journal
|May 9, 2022
Abstract:
Only 0.3-1% of laryngeal cancer are non-squamous cell neoplasms. Of these, a rare entity is inflammatory myofibroblastic tumour (IMT), in which anaplastic lymphoma kinase-1 (ALK-1) is frequently expressed. Just 50 cases of IMT have been reported. Therefore, many otolaryngologists may be unfamiliar with this type of tumour and be prone to its over- or undertreatment.We report a case of ALK-1-negative IMT treated with transoral endoscopic excision and disease-free 6 months after surgery.
